Ames Seed Capital
VC Fund
Ames, United States
Ames Seed Capital is a pool of private investors.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Ames Seed Capital invests in
Stages Ames Seed Capital invests in
Countries Ames Seed Capital invests in
Round sizes
Round size
- Seed
- $100k–$1.2M
Investment Focus
Industry
- Software 2 (33%)
- Health Care 2 (33%)
- B2B 1 (17%)
- Pet 1 (17%)
- PaaS 1 (17%)
Stage
- Seed 3 (50%)
- Series B 1 (17%)
- Series C 1 (17%)
- Convertible Note 1 (17%)
Country
- United States 4 (67%)
- Canada 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
VetMeasure is a developer of a wearable animal health technology harness device designed to remotely monitor health conditions in dogs. The company's device provides accurate detection of an animal's health statistics in real-time, enabling veterinarians and owners to monitor an animal's heart and pulse rates, respiration bodytemperature, and humidity to determine an animal's condition following surgical procedures or illnesses. | $100K / Seed / Aug 12, 2019 | |
|
|
Pitchly provides a SaaS platform for non-technical users to create data-infused real-time PowerPoint and Word documents linked to internal business data wherever it may live. Typically, before Pitchly, this work takes place in disconnected and inefficient tools like Excel, Word, PowerPoint, Sharepoint, or IT-owned databases. The platform aggregatesdisparate information sources, making information easy to catalog, find, and produce compelling and relevant data-driven Word and PowerPoint documents. This generates a 93% reduction in time to create data-heavy documents with 100% error reduction; all in half the time it takes to locate information when compared to traditional approaches.Pitchly end-users can even create custom forms to populate data to those original sources to make certain their teams are using the most relevant and up-to-date data. It aggregates digital data sources, such as Excel, SQL, Salesforce, and more, into one normalized tabular view of the data to reference, search, filter, and then integrate into documents and presentations in real-time. The platform gives the ability to easily publish select information from your database(s) on a website, in various digital forms.The company was founded in 2014 and is headquartered in Des Moines, Iowa. | $650K / Convertible Note / Mar 31, 2019 | |
|
|
A world first, automed is paving the way forward for livestock producers of all sizes. With one single system, you can automatically calculate, deliver and record livestock treatments, and effectively manage your operation. Powerful and easy to use, the automed system integrates easily with existing livestock tools and farm management systems. Theautomed device automatically calculates and delivers both fixed and weight based treatments simply by synchronizing with the automed app. | $400K / Seed / Aug 01, 2018 | |
|
|
FindBoB is a growth, transition and succession planning tool for financial advisors and insurance agents, utilizing machine learning and elements of gamification for asset protection. | $1.2M / Seed / Dec 22, 2017 | |
|
|
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. | $17M / Series C / Jan 31, 2008 | |
|
|
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals andphysician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day. | $8.2M / Series B / Sep 07, 2007 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ames Seed Capital invest in?
Ames Seed Capital invests primarily in Software, Health Care and B2B startups, most often at Seed and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ames Seed Capital's check size?
Ames Seed Capital typically joins rounds of $100k–$1.2M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ames Seed Capital participates in.
When did Ames Seed Capital last invest?
The most recent investment recorded for Ames Seed Capital closed in Aug 2019. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!